Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy U Lin

Showing results (141-150 of 330) with videos related to

Pageof 33
Sort By:
Breast Cancer Research and Treatment|April 24, 2021
Factors associated with late risks of breast cancer-specific mortality in the SEER registryJosé P Leone, Carlos T Vallejo, Michael J Hassett, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastasesMichael A Dyer, Paul J Kelly, Yu-Hui Chen, et al.
Breast Cancer Research and Treatment|July 7, 2021
Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registryJosé P Leone, Carlos T Vallejo, Michael J Hassett, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2022
Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' toolJosé P Leone, Noah Graham, Sara M Tolaney, et al.
Annals of Surgical Oncology|August 8, 2022
Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative ImmunotherapyElizabeth A Mittendorf, Olga Kantor, Anna Weiss, et al.
Breast Cancer Research : BCR|October 3, 2012
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
JAMA Network Open|December 16, 2024
Cannabidiol for Scan-Related Anxiety in Women With Advanced Breast Cancer: A Randomized Clinical TrialManan M Nayak, Peter Chai, Paul J Catalano, et al.
NPJ Breast Cancer|August 29, 2025
The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE studyKristen D Brantley, Gregory J Kirkner, Melissa E Hughes, et al.
Breast Cancer Research and Treatment|October 21, 2024
Patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive breast cancerShoshana M Rosenberg, Yue Zheng, Katheryn Santos, et al.
Breast Cancer Research : BCR|November 30, 2006
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, et al.
Pageof 33

Showing results (141-150 of 330) with videos related to

Sort By:
Pageof 33
Breast Cancer Research and Treatment|April 24, 2021
Factors associated with late risks of breast cancer-specific mortality in the SEER registryJosé P Leone, Carlos T Vallejo, Michael J Hassett, et al.
International Journal of Radiation Oncology, Biology, Physics|June 19, 2012
Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastasesMichael A Dyer, Paul J Kelly, Yu-Hui Chen, et al.
Breast Cancer Research and Treatment|July 7, 2021
Correction to: Factors associated with late risks of breast cancer‑specific mortality in the SEER registryJosé P Leone, Carlos T Vallejo, Michael J Hassett, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2022
Estimating long-term mortality in women with hormone receptor-positive breast cancer: The 'ESTIMATE' toolJosé P Leone, Noah Graham, Sara M Tolaney, et al.
Annals of Surgical Oncology|August 8, 2022
Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative ImmunotherapyElizabeth A Mittendorf, Olga Kantor, Anna Weiss, et al.
Breast Cancer Research : BCR|October 3, 2012
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort studyInes Vaz-Luis, Rebecca A Ottesen, Melissa E Hughes, et al.
JAMA Network Open|December 16, 2024
Cannabidiol for Scan-Related Anxiety in Women With Advanced Breast Cancer: A Randomized Clinical TrialManan M Nayak, Peter Chai, Paul J Catalano, et al.
NPJ Breast Cancer|August 29, 2025
The association between young age at metastatic breast cancer diagnosis and overall survival in the EMBRACE studyKristen D Brantley, Gregory J Kirkner, Melissa E Hughes, et al.
Breast Cancer Research and Treatment|October 21, 2024
Patient-reported outcomes, and perceptions and knowledge about recurrence in women with hormone receptor-positive breast cancerShoshana M Rosenberg, Yue Zheng, Katheryn Santos, et al.
Breast Cancer Research : BCR|November 30, 2006
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342Lyndsay N Harris, Gloria Broadwater, Nancy U Lin, et al.
Pageof 33